Covered recipient · General Payments record
ELISABET E MANASANCH
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2023
$148,709.22
- Reported across 134 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $9,871.75 | 4 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,845.00 | 1 |
| Food and Beverage | $164.49 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $5,635.75 | 2 |
| PFIZER INC. | $4,845.00 | 1 |
| Janssen Biotech, Inc. | $2,198.16 | 2 |
| E.R. Squibb & Sons, L.L.C. | $2,076.00 | 1 |
| Genentech, Inc. | $126.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,076.00 | 02/13/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1016097853 | CMS |
| Genentech, Inc. | $126.33 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040355673 | CMS |
| Janssen Biotech, Inc. | $2,160.00 | 07/02/2023 | Consulting Fee | Undisputed | 01/23/2026 | 988410623 | CMS |
| Janssen Biotech, Inc. | $38.16 | 07/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988410633 | CMS |
| PFIZER INC. | $4,845.00 | 01/13/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Undisputed | 01/23/2026 | 1050638193 | CMS |
| SANOFI-AVENTIS U.S. LLC | $3,576.00 | 06/08/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1050142051 | CMS |
| SANOFI-AVENTIS U.S. LLC | $2,059.75 | 06/23/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1050142035 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.